전체뉴스 1-10 / 618건
- 최신순
- 정확도순
- 과거순
-
[Kyung Hee University Campus Town Startups 2025] “Wellness Box,” developing an AI-powered, pharmacy-based platform for customized, small-batch nutritional supplement delivery
... recommendations, pharmacists at physical pharmacies conduct additional reviews and prepare small batches. They take into account the patient's medications and condition to ensure safety and professionalism." Another strength is the expert-reviewed recommendation ...
한국경제 | 2025.07.14 20:13 | 이진호
-
[Kyung Hee University Campus Town Startups 2025] Dr.B Lab, a startup that uses AI-based computer simulations to develop traditional Korean medicine
... chemotherapy, surgery, radiation, and hormone therapy. However, some cancers still have a poor prognosis, and the number of cancer patients worldwide continues to increase due to the aging population. Developing new cancer treatments requires significant investments in time and ...
한국경제 | 2025.06.26 18:19 | 이진호
-
[COVER STORY - FOCUS] 3D 바이오프린팅의 핵심 소재, 바이오잉크의 활용
... 12 753 [13] Jeong W, Han J, Choi J and Kang H W (2025) Embedded Bioprinting of Breast Cancer–Adipose Composite Tissue Model for Patient‐Specific Paracrine Interaction Analysis Advanced Healthcare Materials 14 2401887 [14] Engler A J, Sen S, Sweeney H L and Discher D E ...
바이오인사이트 | 2025.06.20 08:47 | 김예나
-
[Kyung Hee University's Campus Town Startups 2025] Panacura, a Startup Developing a Stroke Prevention Drug Using Medicinal Herbs as Its Flagship Products
... University Korean Medicine Hospital that is used to prevent ischemic cerebral infarction. It has been used for the past 20 years to treat patients with cerebral stroke and cerebral infarction, and its effectiveness has been proven. PanaCura has signed an agreement with Kyung Hee ...
한국경제 | 2025.06.18 16:57 | 이진호
-
[Kyung Hee University's Campus Town Startups 2025] Itphy, Developer of "RingDoc", a Leading Platform for Musculoskeletal Digital Rehabilitation in Korea
... disorders. "Under the philosophy of 'connecting doctors and patients in a single ring,' Itphy provides integrated digital healthcare ... track the functional recovery of post-operative or chronic pain patients with objective reports, helping them to improve patient care efficiency ...
한국경제 | 2025.06.17 22:17 | 이진호
-
인스코비 자회사 APUS, 美 CRO 전문 기관 Prevail과 업무계약 체결…FDA 임상3상 착수
... 최우선 과제로 진행하기로 합의했다. 이에 따라 2025년 6월 FDA와의 C-type 미팅을 시작으로, 3분기 내 프로토콜 조정 및 임상참여 동의서(ICF) 확보 절차를 완료하고, 2026년 1월 첫 환자 투여(FPI, First Patient In)를 목표로 본격적인 임상에 돌입할 예정이다. APUS 관계자는 “이번 중증도 OA 대상 추가 임상3상은 미국 시장 내 빠른 허가를 위한 전략적 절차”라며 “최소한의 비용으로 효율적인 임상 완수를 추진할 계획”이라고 말했다. ...
한국경제 | 2025.06.16 08:52 | WISEPRESS_AI
-
[Kyung Hee University's Campus Town Startups 2025] SleepForest, a Startup Developing an Intelligent Sleep Management Platform from Content to Commerce
... (54), a professor of neurology at Kangdong Kyung Hee University Hospital. CEO Shin has been a sleep specialist for 27 years, treating patients with sleep disorders. With the motto of "creating a world where everyone gets a good sleep," SleepForest has developed ...
한국경제 | 2025.06.11 08:53 | 이진호
-
[Kyung Hee University's Campus Town Startups 2025] Seolarae, a Traditional Korean Food Brand Made with Ingredients Selected by Herbalists
... directly involved in the entire process. When we operated an offline herbal pharmacy and provided more detailed health counseling to patients, the repurchase rate of our herbal products increased. Our current offline counseling service has been developed in the form of artificial ...
한국경제 | 2025.06.10 17:02 | 이진호
-
[Kyung Hee University's Campus Town Startups 2025] AI-Powered Medical Education Platform "MyMerci" with over 10 Million Learning Records in One Year
... the wrong answer, or to reason about what was the intent of the question. This allows the users to see how it is being applied to patients in the clinical cases, what are the medical applications of this concept that they need to know, and it recommends the latest medical ...
한국경제 | 2025.06.04 17:31 | 이진호
-
그래디언트 바이오컨버전스 "바이오마커로 EGFR 표적항암제 적용처 늘릴 것"
... 플랫폼을 활용한 바이오마커 검증 및 데이터 비교에 긴밀히 협력할 예정이다. 먼저 양사는 메딕 라이프 사이언스가 발굴한 바이오마커 후보가 기존의 3D 세포배양 모델에서 보인 반응을 그래디언트 바이오컨버전스의 환자유래 오가노이드(Patient-Derived Organoid, PDO) 모델에서도 일관되게 재현할 수 있는지를 검증하는 공동 프로젝트에 착수한다. 이후 비소세포폐암 PDO의 유전체 및 전사체 데이터를 활용해 환자군을 특정 바이오마커 기반으로 군집화하고, 다양한 ...
바이오인사이트 | 2025.05.23 16:12 | 이우상
